Loading the player...


INFO:
Fintel reports that on July 21, 2023, Morgan Stanley reiterated coverage of Abbott Laboratories (NYSE:ABT) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 10.58% Upside
Morgan Stanley Reiterates Abbott Laboratories (ABT) Equal-Weight Recommendation | Nasdaq